Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system

被引:17
作者
Griffin, Jan M. [1 ]
DeFilippis, Ersilia M. [1 ]
Rosenblum, Hannah [1 ]
Topkara, Veli K. [1 ]
Fried, Justin A. [1 ]
Uriel, Nir [1 ]
Takeda, Koji [2 ]
Farr, Maryjane A. [1 ]
Maurer, Mathew S. [1 ]
Clerkin, Kevin J. [1 ]
机构
[1] Columbia Univ, Dept Med, Milstein Div Cardiol, Vagelos Coll Phys & Surg, New York, NY USA
[2] Columbia Univ, Dept Surg, Vagelos Coll Phys & Surg, Div Cardiothorac Surg, New York, NY USA
关键词
HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TRANSPLANTATION; AMYLOID CARDIOMYOPATHY; SURVIVAL; FAILURE; LUNG;
D O I
10.1111/ctr.14109
中图分类号
R61 [外科手术学];
学科分类号
摘要
The new heart transplantation (HT) allocation policy was introduced on 10/18/2018. Using the UNOS registry, we examined early outcomes following HT for restrictive cardiomyopathy, hypertrophic cardiomyopathy, cardiac sarcoidosis, or cardiac amyloidosis compared to the old system. Those listed who had an event (transplant, death, or waitlist removal) prior to 10/17/2018 were in Era 1, and those listed on or after 10/18/2018 were in Era 2. The primary endpoint was death on the waitlist or delisting due to clinical deterioration. A total of 1232 HT candidates were included, 855 (69.4%) in Era 1 and 377 (30.6%) in Era 2. In Era 2, there was a significant increase in the use of temporary mechanical circulatory support and a reduction in the primary endpoint, (20.9 events per 100 PY (Era 1) vs. 18.6 events per 100 PY (Era 2), OR 1.98, p = .005). Median waitlist time decreased (91 vs. 58 days, p < .001), and transplantation rate increased (119.0 to 204.7 transplants/100 PY for Era 1 vs Era 2). Under the new policy, there has been a decrease in waitlist time and waitlist mortality/delisting due to clinical deterioration, and an increase in transplantation rates for patients with infiltrative, hypertrophic, and restrictive cardiomyopathies without any effect on post-transplant 6-month survival.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Heart Transplantation for Hypertrophic Cardiomyopathy: The Tufts Experience [J].
Abt, Patrick ;
Rowin, Ethan J. ;
Maron, Barry ;
Kiernan, Michael ;
Vest, Amanda ;
Constantino, Fred ;
Maron, Martin ;
DeNofrio, David .
JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) :S23-S24
[2]  
[Anonymous], 2018, Organ procurement and transplantation network
[3]   Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation [J].
Barrett, Christopher D. ;
Alexander, Kevin M. ;
Zhao, Hongyu ;
Haddad, Francois ;
Cheng, Paul ;
Liao, Ronglih ;
Wheeler, Matthew T. ;
Liedtke, Michaela ;
Schrier, Stanley ;
Arai, Sally ;
Weisshaar, Dana ;
Witteles, Ronald M. .
JACC-HEART FAILURE, 2020, 8 (06) :461-468
[4]   Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation [J].
Cisneros, Julio Zuniga ;
Stehlik, Josef ;
Selzman, Craig H. ;
Drakos, Stavros G. ;
McKellar, Stephen H. ;
Wever-Pinzon, Omar .
CIRCULATION-HEART FAILURE, 2018, 11 (03) :e004378
[5]   An early investigation of outcomes with the new 2018 donor heart allocation system in the United States [J].
Cogswell, Rebecca ;
John, Ranjit ;
Estep, Jerry D. ;
Duval, Sue ;
Tedford, Ryan J. ;
Pagani, Francis D. ;
Martin, Cindy M. ;
Mehra, Mandeep R. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (01) :1-4
[6]   Lung and Heart Allocation in the United States [J].
Colvin-Adams, M. ;
Valapour, M. ;
Hertz, M. ;
Heubner, B. ;
Paulson, K. ;
Dhungel, V. ;
Skeans, M. A. ;
Edwards, L. ;
Ghimire, V. ;
Waller, C. ;
Cherikh, W. S. ;
Kasiske, B. L. ;
Snyder, J. J. ;
Israni, A. K. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (12) :3213-3234
[7]   Cardiac transplantation for hypertrophic cardiomyopathy: A valid therapeutic option [J].
Coutu, M ;
Perrault, LP ;
White, M ;
Pelletier, GB ;
Racine, N ;
Poirier, NC ;
Carrier, M .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (04) :413-417
[8]   A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis [J].
Crawford, Todd C. ;
Okada, David R. ;
Magruder, J. Trent ;
Fraser, Charles ;
Patel, Nishant ;
Houston, Brian A. ;
Whitman, Glenn J. ;
Mandal, Kaushik ;
Zehr, Kenton J. ;
Higgins, Robert S. ;
Chen, Edward S. ;
Tandri, Hari ;
Kasper, Edward K. ;
Tedford, Ryan J. ;
Russell, Stuart D. ;
Gilotra, Nisha A. .
JOURNAL OF CARDIAC FAILURE, 2018, 24 (06) :384-391
[9]   Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era [J].
Davis, M. K. ;
Kale, P. ;
Liedtke, M. ;
Schrier, S. ;
Arai, S. ;
Wheeler, M. ;
Lafayette, R. ;
Coakley, T. ;
Witteles, R. M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (03) :650-658
[10]   The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary [J].
Feldman, David ;
Pamboukian, Salpy V. ;
Teuteberg, Jeffrey J. ;
Birks, Emma ;
Lietz, Katherine ;
Moore, Stephanie A. ;
Morgan, Jeffrey A. ;
Arabia, Francisco ;
Bauman, Mary E. ;
Buchholz, Hoger W. ;
Deng, Mario ;
Dickstein, Marc L. ;
El-Banayosy, Aly ;
Elliot, Tonya ;
Goldstein, Daniel. J. ;
Grady, Kathleen L. ;
Jones, Kylie ;
Hryniewicz, Katarzyna ;
John, Ranjit ;
Kaan, Annemarie ;
Kusne, Shimon ;
Loebe, Matthias ;
Massicotte, M. Patricia ;
Moazami, Nader ;
Mohacsi, Paul ;
Mooney, Martha ;
Nelson, Thomas ;
Pagani, Francis ;
Perry, William ;
Potapov, Evgenij V. ;
Rame, Eduardo ;
Russell, Stuart D. ;
Sorensen, Erik N. ;
Sun, Benjamin ;
Strueber, Martin ;
Mangi, Abeel A. ;
Petty, Michael G. ;
Rogers, Joseph .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (02) :157-187